Cancer hazards of the pharmacy.
D000818:Animals; D001151:Arsenic / Q000009:adverse effects; D002273:Carcinogens; D004967:Estrogens / Q000009:adverse effects; D006118:Griseofulvin / Q000009:adverse effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007538:Isoniazid / Q000009:adverse effects; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects; D011859:Radiography / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects; D051381:Rats; D013449:Sulfonamides / Q000009:adverse effects; D013911:Thorium Dioxide / Q000009:adverse effects; D014343:Trypan Blue / Q000009:adverse effects; D014520:Urethane / Q000009:adverse effects
D002273:Carcinogens; D004967:Estrogens; D007004:Hypoglycemic Agents; D009588:Nitrogen Mustard Compounds; D013449:Sulfonamides; D006118:Griseofulvin; D014520:Urethane; D013911:Thorium Dioxide; D014343:Trypan Blue; D001151:Arsenic; D007538:Isoniazid